Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
Japan · Delayed Price · Currency is JPY 307.00
+3.00 (0.99%)
Aug 7, 2025, 3:30 PM JST
Wakamoto Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | 2003 - 2007 |
|---|---|---|---|---|---|---|
Period Ending | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | 2003 - 2007 |
Net Income | -127 | -626 | 48.52 | 351.36 | 406.89 | Upgrade |
Depreciation & Amortization | 1,008 | 1,204 | 720.1 | 553.41 | 512.27 | Upgrade |
Loss (Gain) From Sale of Assets | -123 | 45 | 10.48 | 9.41 | 14.44 | Upgrade |
Loss (Gain) From Sale of Investments | 24 | 34 | 3.32 | - | - | Upgrade |
Other Operating Activities | -24 | -3 | -66.87 | 40.3 | -115.6 | Upgrade |
Change in Accounts Receivable | 392 | 107 | 95.95 | 220.18 | 313.06 | Upgrade |
Change in Inventory | -105 | -533 | 110.95 | -237.64 | -70.85 | Upgrade |
Change in Accounts Payable | -426 | 427 | -234.51 | 130.8 | -54.84 | Upgrade |
Change in Other Net Operating Assets | -30 | -309 | -198.54 | -243.23 | -111.2 | Upgrade |
Operating Cash Flow | 589 | 346 | 489.39 | 824.58 | 894.17 | Upgrade |
Operating Cash Flow Growth | 70.23% | -29.30% | -40.65% | -7.78% | 0.63% | Upgrade |
Capital Expenditures | -391 | -467 | -2,610 | -1,826 | -645.33 | Upgrade |
Sale of Property, Plant & Equipment | 144 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -237 | -10 | -17.61 | -1 | -12.71 | Upgrade |
Investment in Securities | 38 | 199 | -26.85 | 1,638 | -1,014 | Upgrade |
Other Investing Activities | -59 | -38 | -0 | -0 | -0 | Upgrade |
Investing Cash Flow | -505 | -316 | -2,654 | -189.32 | -1,672 | Upgrade |
Short-Term Debt Issued | 100 | - | - | - | - | Upgrade |
Long-Term Debt Issued | 300 | - | 1,600 | - | - | Upgrade |
Total Debt Issued | 400 | - | 1,600 | - | - | Upgrade |
Long-Term Debt Repaid | -196 | -174 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | 204 | -174 | 1,600 | - | - | Upgrade |
Issuance of Common Stock | - | 118 | - | - | 838 | Upgrade |
Repurchase of Common Stock | -3 | -8 | -17.67 | -14.56 | -14.45 | Upgrade |
Common Dividends Paid | - | - | -172.34 | -172.77 | -168.59 | Upgrade |
Dividends Paid | -2 | -86 | -172.34 | -172.77 | -168.59 | Upgrade |
Other Financing Activities | -2 | - | -0 | -0 | -0 | Upgrade |
Financing Cash Flow | 197 | -150 | 1,410 | -187.33 | 654.96 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1 | - | - | -0 | 0 | Upgrade |
Net Cash Flow | 282 | -120 | -754.83 | 447.93 | -122.9 | Upgrade |
Free Cash Flow | 198 | -121 | -2,120 | -1,001 | 248.84 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -28.23% | Upgrade |
Free Cash Flow Margin | 2.10% | -1.25% | -21.69% | -9.93% | 2.45% | Upgrade |
Free Cash Flow Per Share | 5.69 | -3.50 | -61.62 | -29.07 | 7.34 | Upgrade |
Cash Interest Paid | 28 | 28 | 14.34 | - | - | Upgrade |
Cash Income Tax Paid | 21 | 3 | 141.13 | 215.71 | 425.97 | Upgrade |
Levered Free Cash Flow | -241 | -83.66 | -3,006 | -454.68 | 510.48 | Upgrade |
Unlevered Free Cash Flow | -223.5 | -66.78 | -2,994 | -454.68 | 510.48 | Upgrade |
Change in Net Working Capital | 291 | 321.28 | 1,072 | -691.64 | -274.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.